Cardiovascular Clinical Consult Diabetes Generics Gut Health Heart Health Immunization Migraine Oncology Respiratory Shingles Technology ThoughtSpot 2020

Cardiovascular Clinical Consult DiabetesGenericsGut HealthHeart HealthImmunizationMigraineOncologyRespiratoryShinglesTechnologyThoughtSpot 2020

Clinical

View More Anticoagulants Autoimmune Diseases Biosimilars CBD COPD Management Coronavirus Dermatology Diabetes Generics Gut Health Heart Health Immunization Influenza Oncology Pain Management Pediatrics Respiratory Shingles

AnticoagulantsAutoimmune DiseasesBiosimilarsCBDCOPD ManagementCoronavirusDermatologyDiabetesGenericsGut HealthHeart HealthImmunizationInfluenzaOncologyPain ManagementPediatricsRespiratoryShingles

News

All News Association News Clinical News Legal News Managed Care News New Products Technology Viewpoints

All NewsAssociation NewsClinical NewsLegal NewsManaged Care NewsNew ProductsTechnologyViewpoints

Media

Expert Interviews Medical World News Podcasts

Expert InterviewsMedical World NewsPodcasts

Practice Type

Chain Pharmacy Community Practice Health Systems

Chain PharmacyCommunity PracticeHealth Systems

Conferences

Conference Coverage Conference Listing

Conference CoverageConference Listing

Publications

Drug Topics Journal Sponsored Resources

Drug Topics JournalSponsored Resources

Careers CME/CE

eNewsletter Print Subscription

eNewsletterPrint Subscription

Advertise
Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

Cardiovascular Clinical Consult
Diabetes
Generics
Gut Health
Heart Health
Immunization
Migraine
Oncology
Respiratory
Shingles
Technology
ThoughtSpot 2020

ClinicalSee All >

Anticoagulants
Autoimmune Diseases
Biosimilars
CBD
COPD Management
Coronavirus
Dermatology
Diabetes
Generics
Gut Health
Heart Health
Immunization
Influenza
Oncology
Pain Management
Pediatrics
Respiratory
Shingles

Advertise
Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

New leucovorin isomer gets FDA nod

March 12, 2008

Spectrum Pharmaceuticals receives FDA approval for levoleucovorin.